Dr. Ricardo T.d.d. Carter, MD

Dr. Carter practices at Geisinger Lewistown Hospital in Lewistown, Pennsylvania, part of Risant Health.

Dr. Carter's NPI, 1669457065, was assigned on December 8, 2005. Dr. Carter graduated from Autonomous University of Baja California School of Medicine in 1981. Dr. Carter holds Pennsylvania license MD041163E.

Dr. Carter's primary practice is Geisinger Lewistown Hospital, at 400 Highland Avenue, Lewistown, PA 17044 in Mifflin County. The practice phone is (717) 248-5411.

Dr. Carter's primary practice is Geisinger Lewistown Hospital in Lewistown, Pennsylvania, part of Risant Health. Dr. Carter is also affiliated with Geisinger Medical Center. The medical group on file is Geisinger. Dmand AI also links Dr. Carter to 2 more hospitals, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carter practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Carter's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Carter is licensed in Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Carter treats.

CMS data shows 14,525 Medicare services from Dr. Carter across 12 procedure codes in 2024, for 184 Medicare patients. Medicare paid $255,152 for them.

CMS counts 184 Medicare patients who saw Dr. Carter in 2024. The largest group is 75 to 84, with 80 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carter's median patient age at 75, with 62% women.

In 2024, Dr. Carter wrote 1,643 Medicare Part D claims for 162 patients. 88% of them were for generic drugs. CMS names the drug for 1,316 of them, across 39 drugs with 11 or more claims each, at $1,084,175 in total drug cost. In 2023, CMS named 1,339 claims across 40 drugs.

Dr. Carter accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 30 general payments to Dr. Carter from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. US Oncology Corporate, Inc. paid the most, $938.

Dr. Carter graduated from Autonomous University of Baja California School of Medicine in 1981. Dr. Carter is a member of ACP and ASCO.

Dr. Carter is in network with 8 carriers, including Aetna, Highmark and Capital Blue Cross. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.